Arsenic Trioxide Accord – Package Leaflet: InfoCons – Consumer Protection presents, in an accessible format, the official package leaflet of the medicine Arsenic Trioxide Accord, as authorised in the European Union and published in the Union Register of medicinal products.
Before anything else
Read all of this leaflet carefully before you are given this medicine because it contains important information for you.
- Keep this leaflet. You may need to read it again.
- If you have further questions, please ask your doctor , pharmacist or nurse.
- If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.
ℹ️ 1. What Arsenic trioxide Accord is and what it is used for
Arsenic trioxide Accord is used in adult patients with newly diagnosed low -to-intermediate risk acute promyelocytic leukaemia (APL), and in adult patients, whose disease has not responded to other therapies. APL is a unique type of myeloid leukaemia, a disease in which abnormal white blood cells and abnormal bleeding and bruising occur.
⚠️ 2. What you need to know before you are given Arsenic trioxide Accord
Arsenic trioxide Accord must be given under the supervision of a physician experienced in the treatment of acute leukaemias.
You must not receive If you are allergic to arsenic trioxide or any of the other ingredients of this medicine (listed in section 6).
Warnings and precautions
You must talk to your doctor or nurse before you are given Arsenic trioxide Accord , if
- you have impaired kidney function.
- you have any liver problems.
Your doctor will take the following precautions:
- Tests will be performed to check the amount of potassium, magnesium, calcium and creatinine in your blood before your first dose of Arsenic trioxide Accord .
- You should have an electrical recording of the heart (electrocardiogram ECG) performed before your first dose.
- Blood tests (potassium, calcium, magnesium and liver function) should be repeated during your treatment with Arsenic trioxide Accord .
- In addition, you will receive electrocardiograms twice weekly.
- If you are at risk for a certain type of abnormal heart rhythm (e.g. torsade de pointes or QTc prolongation), your heart will be monitored continuously.
- Your doctor may monitor your health during and after treatment, since arsenic trioxide, the active substance in Arsenic trioxide Accord , may cause other cancers. You should report any new and exceptional symptoms and circumstances whenever you see your doctor.
- Follow -up of your cognitive and mobility functions if you are at risk for vitamin B1 deficiency.
Children and adolescents
Arsenic trioxide Accord is not recommended in children and adolescents below 18 years of age.
Other medicines and Arsenic trioxide Accord
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.
In particular tell your doctor
- if you are taking any of various types of medicines which could cause a change in the rhythm of your heartbeat. These include:
- some types of antiarrhythmics (medicines used to correct irregular heart beats, e.g. quinidine, amiodarone, sotalol, dofetilide)
- medicines to treat psychosis (loss of contact with reality, e.g. thioridazine)
- medicines for depression (e.g. amitriptyline)
- some types of medicines to treat bacterial infections (e.g. erythromycin and sparfloxacin)
- some medicines to treat allergies such as hay fever, called antihistamines (e.g. terfenadine and astemizole)
- any medicines that cause a decrease in magnesium or potassium in your blood (e.g. amphotericin B)
- cisapride (a medicine used to relieve certain stomach problems).
The effect of these medicines on your heartbeat can be made worse by Arsenic trioxide Accord .
You must be sure to tell your doctor about all medicines you are taking.
- if you are taking or have recently taken any medicine which may affect your liver. If you are not sure, show the bottle or pack to your doctor.
Arsenic trioxide Accord with food and drink There are no restrictions on your food or drink while you are receiving Arsenic trioxide Accord .
Pregnancy
Ask your doctor or pharmacist for advice before taking any medicine.
Arsenic trioxide Accord may cause harm to the foetus when used by pregnant women.
If you are able to become pregnant, you must use effective birth control during treatment with Arsenic trioxide Accord and for 6 months followi ng completion of treatment .
If you are pregnant or you become pregnant during the treatment with Arsenic trioxide Accord , you must ask your doctor for advice.
Men should also use effective contraception and be advised to not father a child while receiving Arsenic trioxide Accord and for 3 months following completion of treatment .
Breast -feeding Ask your doctor or pharmacist for advice before taking any medicine. The arsenic in Arsenic trioxide Accord passes into breast milk.
Because Arsenic trioxide Accord can harm nursing infants, do not breast -feed while on and until two weeks after the last dose of Arsenic trioxide Accord .
Driving and using machines
Arsenic trioxide Accord is expected to have no or negligible influence on your ability to drive and use machines. If you experience discomfort or if you feel unwell after a Arsenic trioxide Accord injection, you should wait until the symptoms go away before driving or using machines.
Arsenic trioxide Accord contains sodium
This medicine contains less than 1 mmol sodium (23 mg) per dose. This means that the medicine is essentially “sodium -free”.
💊 3. How Arsenic trioxide Accord is given
Duration and frequency of treatment Patients with newly diagnosed acute promyelocytic leukaemia Your doctor will give you Arsenic trioxide Accord once every day as an infusion. In your first treatment cycle, you may be treated every day up to 60 days at most or until your doctor determines that your disease is better. If your disease responds to Arsenic trioxide Accord , you will be given 4 additional treatment cycles . Each cycle consists of 20 doses given 5 days per week (followed by 2 days interruption) for 4 weeks followed by 4 weeks interruption. Your doctor will decide exactly how long you must continue on therapy with Arsenic trioxide Accord .
Patients with acute promyelocytic leukaemia, whose disease has not responded to other therapies Your doctor will give you Arsenic trioxide Accord once every day as an infusion. In your first treatment cycle, you may be treated every day up to 50 days at most or until your doctor determines that your disease is better. If your disease responds to Arsenic trioxide Accord , you will be given a second treatment cycle of 25 doses given 5 days per week (followed by 2 days interruption) for 5 weeks. Your doctor wil l decide exactly how long you must continue on therapy with Arsenic trioxide Accord .
Method and route of administration Arsenic trioxide Accord must be diluted with a solution containing glucose or a solution containing sodium chloride.
Arsenic trioxide Accord is normally given by a doctor or a nurse. It is given as a drip (infusion) into a vein over 1 -2 hours, but the infusion may last longer if side effects like flushing and dizziness occur.
Arsenic trioxide Accord must not be mixed with, or infused through the same tube with other medicines.
If your doctor or nurse gives you more Arsenic trioxide Accord than he/she should You may experience convulsions, muscle weakness and confusion. If this happens, treatment with Arsenic trioxide Accord must be stopped immediately and your doctor will treat the arsenic overdose.
If you have any further question on the use of this medicine, ask your doctor , pharmacist or nurse .
❗ 4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Tell your doctor or nurse straight away if you notice the following side effects, as these may be signs of a severe condition called “differentiation syndrome”, which might be fatal :
- difficulty in breathing
- coughing
- chest pain
- fever Tell your doctor or nurse straight away if you notice one or more of the following side effects, as these may be signs of allergic reaction:
- difficulty in breathing
- fever
- sudden weight gain
- water retention
- fainting
- palpitations (strong heartbeat you can feel in your chest) While on treatment with Arsenic trioxide Accord , you may experience some of the following reactions:
Very common (may affect more than 1 in 10 people)
- fatigue (weariness), pain, fever, headache
- nausea, vomiting, diarrhoea
- dizziness, muscle pain, numbness or tingling
- rash or itching, increased blood sugar, oedema (swelling due to excess fluid)
- shortness of breath, fast heart beat, abnormal ECG heart tracing
- reduced potassium or magnesium in the blood, liver function tests abnormal including presence of excess bilirubin or gamma -glutamyltransferase in the blood
Common (may affect up to 1 in 10 people)
- reduction in blood cell counts (platelets, red and/or white blood cells), increased white blood cells
- chills, increased weight
- a fever due to an infection and low levels of white blood cells, herpes zoster infection
- chest pain, bleeding in the lung, hypoxia (low oxygen level), collection of fluid around the heart or the lung, low blood pressure, abnormal heart rhythm
- fit, joint or bone pain, inflammation of the blood vessels
- increased sodium or magnesium, ketones in the blood and urine (ketoacidosis), renal function tests abnormal, kidney failure
- stomach (abdominal) ache
- redness of the skin, swollen face, blurred vision
Not known (frequency cannot be estimated from the available data)
- lung infection, infection in the blood
- inflammation of the lungs which causes chest pain and breathlessness, cardiac failure
- dehydration, confusion
- Cerebral disease (Encephalopathy, Wernicke encephalopathy) with various manifestations including difficulties to use arms and legs, speech disorders and confusion
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V . By reporting side effects you can help provide more information on the safety of this medicine.
🌡️ 5. How to store Arsenic trioxide Accord
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the vial label and the carton. This medicine does not require any special storage conditions.
After first opening: Once opened the product should be used immediately.
Shelf life after dilution: Chemical and physical in -use stability has been demonstrated for 168 hours at 25 °C and at 2°C to 8°C. From a microbiological point of view, the product must be used immediately.
If not used immediately, in -use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2°C -8°C, unless dilution has taken place in controlled and validated aseptic conditions.
This medicine must not be used if you notice foreign particulate matter or if the solution is discoloured.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
📦 6. Contents of the pack and other information
What Arsenic trioxide Accord contains
- The active substance is arsenic trioxide One mL of concentrate contains 1 m g arsenic trioxide.
One vial contains 10 mg of arsenic trioxide.
- The other ingredients are sodium hydroxide, concentrated hydrochloric acid (for pH adjustment)
and water for injections . See section 2, “Arsenic trioxide Accord contains sodium”.
What Arsenic trioxide Accord looks like and contents of the pack
Arsenic trioxide Accord is a concentrate for solution for infusion. Arsenic trioxide Accord is supplied in glass vials as a concentrated, sterile, clear, colourless, aqueous solution .
Each carton contains 1, 5 or 10 vials.
Not all pack sizes may be marketed.
Marketing Authorisation Holder
Accord Healthcare S.L.U.
World Trade Center, Moll de Barcelona S/N, Edifici Est, 6a planta, 08039 Barcelona, Spain
Manufacturer
Accord Healthcare Polska Sp.z o.o. , ul. Lutomierska 50, 95-200 Pabianice, Poland For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
AT / BE / BG / CY / CZ / DE / DK / EE / FI / FR / HR / HU / IE / IS / IT / LT / LV / LX / MT / NL / NO / PT / PL / RO / SE / SI / SK / ES Accord Healthcare S.L.U.
Tel: +34 93 301 00 64 EL Win Medica Pharmaceutical S.A.
Tel: +30 210 7488 821
This leaflet was last revised in {MM/YYYY}
Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu —————————————————————————————————————————
🩺 Information intended for healthcare professionals only
ASEPTIC TECHNIQUE MUST BE STRICTLY OBSERVED THROUGHOUT HANDLING OF ARSENIC TRIOXIDE ACCORD SINCE NO PRESERVATIVE IS PRESENT.
Dilution of Arsenic trioxide Accord Arsenic trioxide Accord must be diluted before administration. PVC -free plastic bags should be used.
Personnel should be trained to handle and dilute arsenic trioxide and should wear appropriate protective clothing.
Dilution: Carefully insert the needle of a syringe into the vial through the rubber stopper and draw up all of the content. Arsenic trioxide Accord must then be diluted immediately with 100 to 250 ml of glucose 50 mg/ml (5%) solution for injection or sodium chloride 9 mg/ml (0.9%) solution for injection.
Unused portions of each vial must be discarded properly. Do not save any unused portions for later administration.
Use of Arsenic trioxide Accord For single use only. Arsenic trioxide Accord must not be mixed with or concomitantly administered in the same intravenous line with other medicinal products.
Arsenic trioxide Accord must be administered intravenously over 1 -2 hours. The infusion duration may be extended up to 4 hours if vasomotor reactions are observed. A central venous catheter is not required.
The diluted solution must be clear and colourless. All parenteral solutions must be inspected visually for particulate matter and discoloration prior to administration. Do not use the preparation if foreign particulate matter is present.
After dilution in intravenous solutions, Arsenic trioxide Accord is chemically and physically stable for 168 hours at 25°C and at refrigerated (2 -8°C) temperatures. From a microbiological point of view, the product must be used immediately. If not used immediately, in -use storage times and conditions prior to use are the responsibility of the user and would norma lly not be longer than 24 hours at 2 – 8°C, unless dilution has taken place in controlled and validated aseptic conditions.
Procedure for proper disposal Any unused product, any items that come into contact with the product, and waste material must be disposed of in accordance with local requirements.
📄 Package Leaflet – official source
This article reproduces the information in the official package leaflet, as authorised in the European Union. You can consult the original document here: Product information Arsenic Trioxide Accord (PDF, ec.europa.eu).
You can check this medicine at any time in the Union Register of medicinal products (EU number EU/1/19/1398).
⚠️ Important: This article is for information purposes only and does not replace medical advice or the package leaflet inside the medicine box. Read the leaflet carefully before use. For any questions about your treatment, talk to your doctor or pharmacist. If you experience side effects, tell your doctor or pharmacist and report them through your national reporting system.